123259-33-6 Usage
Description
Methyl-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)amine is a bicyclic amine derivative characterized by the presence of a methyl group attached to the benzene ring. This chemical compound is part of the amine class and has garnered interest in the pharmaceutical industry for its potential applications in the development of drugs targeting central nervous system disorders.
Uses
Used in Pharmaceutical Industry:
Methyl-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)amine is utilized as a key component in the development of new drugs aimed at treating central nervous system disorders. Its unique structure and properties make it a promising candidate for creating innovative therapeutic agents.
Used in Organic Synthesis:
In the field of organic synthesis, Methyl-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)amine serves as a valuable building block for the preparation of various functionalized compounds. Its versatility in chemical reactions allows for the creation of a wide range of molecules with diverse applications.
Used in Research and Development:
Methyl-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)amine is extensively employed in research and development settings to explore its specific properties and potential uses. Ongoing studies aim to uncover new applications and optimize its utilization in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 123259-33-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,3,2,5 and 9 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 123259-33:
(8*1)+(7*2)+(6*3)+(5*2)+(4*5)+(3*9)+(2*3)+(1*3)=106
106 % 10 = 6
So 123259-33-6 is a valid CAS Registry Number.
InChI:InChI=1/C10H20N2/c1-11-8-6-9-4-3-5-10(7-8)12(9)2/h8-11H,3-7H2,1-2H3
123259-33-6Relevant articles and documents
Synthesis of a New Class of 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxylic Acid Derivatives as Highly Potent 5-HT3 Receptor Antagonists
Turconi, Marco,Nicola, Massimo,Quintero, Myrna Gil,Maiocchi, Luciano,Micheletti, Rosella,et al.
, p. 2101 - 2108 (2007/10/02)
A series of 2,3-dihydro-2-oxo-1H-benzimidazole-1-carboxylic acid esters and amides containing a basic azacyclo- or azabicycloalkyl moiety has been synthesized and evaluated for 5-HT3 antagonistic activity in a radioligand binding assay (3>ICS 205930) and in the 5-HT-induced von Bezold-Jarisch reflex in the rat.It was found that endosubstituted azabicycloalkyl derivatives (e.g. 7a, 12a, 12b) were much more active than the corresponding exo analogues (e. g. 7b, 12h, 12i) or azacycloalkyl compounds.Amidic derivatives 12a, 12b, 12c, 12e, 13b, and 13c proved to be about 10 tim es more active than the corresponding ester derivatives 7a, 11a, 7d, 8a, and 8b.In particular, compound 12a (DA 6215) showed a Ki=3.8 nM in the binding test and an ED50=1 nM/kg iv in the von Bezold-Jarisch reflex assay, an activity comparable to that of the reference compound 2 (ICS 205930, Ki=2 nM, ED50=2.1 nM/kg).IR spectroscopy studies in the solid state and in CHCl3 solution revealed the existence of an intramolecular hydrogen bond in 13b, taken as a model compound for this class of substances.A molecular modeling study showed that 12a, in its internal hydrogen-bound conformation, well matches a recently proposed pharmacophoric model for 5-HT3 antagonist activity.
